Bimekizumab showed higher PASI100 response rates at weeks 4 and 16 compared to brodalumab, indicating superior efficacy. Discontinuation due to inefficacy was more frequent with brodalumab, though not ...

Following these positive 36-week results, Silence Therapeutics plans to announce 48-week results of the ongoing ALPACAR-360 study in Q2 of 2024. Silence Therapeutics has released promising findings ...

At 36 weeks, you’re officially in your last month of pregnancy! In these last few weeks, your baby’s plumping up, getting in position to come down the birth canal and preparing to interact with you. A ...

Pre-eclampsia is among the most common hypertensive disorders of pregnancy and can have fatal outcomes for both mother and baby. There is currently no proven intervention to reliably reduce the ...

So, your little one couldn’t wait to join you in the big, big world and has decided to make a grand entrance! If your baby is premature, or “preterm,” they’re in good company — about 1 in 10 babies ...